Karyopharm Therapeutics Inc.
KPTI
$1.61
-$0.09-5.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.94% | 29.90% | -41.36% | -65.64% | -66.02% |
| Total Receivables | -9.29% | -33.73% | -14.91% | 0.31% | -14.67% |
| Inventory | -19.99% | -24.53% | -14.79% | -15.11% | 43.61% |
| Prepaid Expenses | -10.20% | -17.09% | -24.98% | -45.57% | -42.37% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.69% | 5.07% | -34.08% | -51.42% | -53.07% |
|
|
|||||
| Total Current Assets | 8.69% | 5.07% | -34.08% | -51.42% | -53.07% |
| Net Property, Plant & Equipment | -18.23% | -22.40% | -25.97% | 55.86% | 40.17% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -65.26% | -65.11% | -63.04% | 2.68% | 2.81% |
| Total Assets | 6.14% | 2.90% | -34.06% | -49.21% | -50.99% |
|
|
|||||
| Total Accounts Payable | 194.96% | -27.13% | -21.62% | -6.76% | -7.15% |
| Total Accrued Expenses | 25.23% | 33.46% | 6.34% | 32.38% | 26.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 442.05% | 3,486.84% | 4,918.04% | 265.92% | 115.32% |
| Total Finance Division Other Current Liabilities | 306.48% | 78.87% | -3.72% | -8.88% | 7.15% |
| Total Other Current Liabilities | 306.48% | 78.87% | -3.72% | -8.88% | 7.15% |
| Total Current Liabilities | 35.29% | 29.80% | -0.22% | 41.73% | 72.19% |
|
|
|||||
| Total Current Liabilities | 35.29% | 29.80% | -0.22% | 41.73% | 72.19% |
| Long-Term Debt | 24.91% | 15.84% | 17.67% | -5.24% | -14.69% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.09% | -15.68% | -14.44% | -- | 554.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 59.64% | 16.53% | 68.64% | -6.19% | -45.06% |
| Total Liabilities | 28.41% | 19.03% | 14.53% | 4.69% | -0.67% |
|
|
|||||
| Common Stock & APIC | 9.61% | 9.76% | 6.44% | 1.10% | 1.20% |
| Retained Earnings | -13.84% | -12.29% | -12.54% | -8.13% | -8.23% |
| Treasury Stock & Other | 116.33% | 113.40% | 119.94% | -16.67% | 58.51% |
| Total Common Equity | -38.19% | -29.03% | -57.47% | -68.66% | -80.81% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -38.19% | -29.03% | -57.47% | -68.66% | -80.81% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -38.19% | -29.03% | -57.47% | -68.66% | -80.81% |
|
|
|||||